XML 65 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock, and Warrants With-Down Round Protection - Schedule of Assumptions Used to Value Options (Details)
12 Months Ended
Dec. 31, 2019
$ / shares
Dividend yield 0.00%
Expected volatility 56.32% [1]
Risk free interest rate 2.50%
Expected term of options 5 years
Stock price $ 0.258 [2]
Minimum [Member]  
Exercise price 0.258
Fair value 0.004
Maximum [Member]  
Exercise price 5.400
Fair value $ 0.134
[1] Due to the low trading volume of the Company's Common Stock, the expected volatility for 2019 grants was based on a sample of 248 companies operating in the Healthcare Products industry, respectively.
[2] The Common Stock price, per share for the year ended December 31, 2019 reflects the Company's management's estimation of the fair value per share of Common Stock. In reaching its estimation for December 31, 2019, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series D Units.